High efficiency activation of L-type Ca2+ current by 5-HT in human atrial myocytes

Receptors and Channels

Volumn 10, Issue 5-6, 2004, Pages 159-165

  Di Scala, Emmanuella ^a   Findlay, Ian ^a   Rose, Stephanie ^a   Aupart, Michel ^b   Argibay, Jorge ^a   Cosnay, Pierre ^a   Bozon, Veronique ^a  

^a UNIVERSITÉ DE TOURS   (France)

^b SERVICE DE DERMATOLOGIE   (France)

Author keywords

Atrial fibrillation; Ca current; cAMP; Human atrial myocytes; Serotonin

Indexed keywords

ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHANNEL L TYPE; CALCIUM ION; CYCLIC AMP; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FORSKOLIN; SEROTONIN;

ADRENERGIC STIMULATION; ADULT; AGED; ARRHYTHMOGENESIS; ARTICLE; CALCIUM CURRENT; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; FEMALE; FREQUENCY ANALYSIS; GENE ACTIVATION; HEART ATRIUM; HEART ATRIUM FIBRILLATION; HEART ELECTROPHYSIOLOGY; HEART MUSCLE CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROTEIN FUNCTION;

ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; CALCIUM; CALCIUM CHANNELS, L-TYPE; CELLS, CULTURED; CYCLIC AMP; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHYSIOLOGY; FEMALE; FORSKOLIN; HEART ATRIA; HUMANS; ISOPROTERENOL; MALE; MIDDLE AGED; MUSCLE CELLS; MYOCARDIUM; SEROTONIN; TIME FACTORS;

EID: 20344395120     PISSN: 10606823     EISSN: None     Source Type: Journal    
DOI: 10.1080/10606820490926115     Document Type: Article

References (30)

1. Allessie, M. A., Ausma, J., and Schotten, U. 2002. Cardiovasc. Res. 54:230-246.
2. Bach, T., Syversveen, T., Kvingedal, A. M., Krobert, K. A., Brattelid, T., Kaumann, A. J., and Levy, F. O. 2001. Naunyn-Schmiedebergs Arch. Pharmacol. 363:146-160.
3. Bers, D. M., and Ziolo, M. T. 2001. Circ. Res. 89:445-452.
4. Blondel, O., Gastineau, M., Langlois, M., and Fischmeister, R. 1998. Br. J. Pharmacol. 124:1-3.
5. Claeysen, S., Sebben, M., Becamel, C., Eglen, R. M., Clark, R. D., Bockaert, J., and Dumuis, A. 2000. Mol. Pharmacol. 58:136-144.
6. Côté, F., Fligny, C., Fromes, Y., Mallet, J., and Vodjani, G. 2004. Trends. Mol. Med. 10:232-238.
7. Georget, M., Mateo, P., Vandecasteele, G., Lipskaia, L., Defer, N., Hanoune, J., Hoerter, J., Lugnier, C., and Fischmeister, R. 2003. FASEB J. 17:1380-1391.
8. Gong, H., Sun, H., Koch, W. J., Rau, T., Eschenhagen, T., Ravens, U., Heubach, J. F., Adamson, D. L., and Harding, S. E. 2002. Circulation 105:2497-2503.
9. Hamill, O. P., Marty, A., Neher, E., Sakmann, B., and Sigworth, F. J. 1981. Plugers. Arch. 391:85-100.
10. Jahnel, U., Rupp, J., Ertl, R., and Nawrath, H. 1992. Naunyn-Schmiedebergs Arch. Pharmacol. 346:482-485.
11. Kaumann, A. J., Sanders, L., Brown, A. M., Murray, K. J., and Brown, M. J. 1990. Br. J. Pharmacol. 100:879-885.
12. Kaumann, A. J. 1994. Trends. Pharmacol. Sci. 15:451-455.
13. Kaumann, A. J., and Sanders, L. 1994. Naunyn-Schmiedebergs Arch. Pharmacol. 349:331-337.
14. Kaumann, A. J., Lynham, J. A., Brown, A. M. 1995. Naunyn-Schmiedebergs Arch. Pharmacol. 353:592-595.
15. Kilts, J. D., Gerhardt, M. A., Richardson, M. D., Sreeram, G., Mackensen, B., Grocott, H. P., White, W. D., Davis, R. D., Newman, M. F., Reves, J. G., Schwinn, D. A., and Kwatra, M. M. 2000. Circ. Res. 87:705-709.
16. Mialet, J., Berque-Bestel, I., Eftekhari, P., Gastineau, M., Giner, M., Dahmoune, Y., Donzeau-Gouge, P., Hoebeke, J., Langlois, M., Siscic, S., Fischmeister, R., and Lezoualc'h, F. 2000. Brit. J. Pharmacol. 129:771-781.
17. Nattel, S. 2002. Nature 415:219-226.
18. Ouadid, H., Seguin, J., Dumuis, A., Bockaert, J., and Nargeot, J. 1991. Mol. Pharmacol. 41:346-351.
19. Pau, D., Workman, A. J., Kane, K. A., and Rankin, A. C. 2003. Br. J. Pharmacol. 140:1434-1441.
20. Rich, T., Fagan, K. A., Tse, T. E., Schaack, J., Cooper, D. M., Karpen, J. W. 2001. Proc. Natl. Acad. Sci. USA 98:13049-13054.
21. Sallé, L., Eftekhari, P., Aupart, M., Cosnay, P., Hoebeke, J., and Argibay, J. 2001. J. Mol. Cell. Cardiol. 33:405-417.
22. Sanders, L., and Kaumann, A. J. 1992. Naunyn-Schmiedebergs Arch. Pharmacol. 345:382-386.
23. Sanders, L., Lynham, J. A., Bond, B., del Monte, F., Harding, S. E., and Kaumann, A. J. 1995. Circ. Res. 92:2527-2539.
24. Simonds, W. 1999. Trends Pharmacol. Sci. 20:66-72.
25. Steinberg, S. F., and Brunton, L. L. 2001. Annu. Rev. Pharmacol. Toxicol. 41:751-773.
26. Tipparaju, S. M., Kumar, R., Wang, Y., Joyner, R. W., Wagner, M. B. 2004. Am. J. Physiol. Heart. Circ. Physiol. 286:H1963-H1969.
27. Workman, A. J., Rankin, A. C. 1998. Cardiovasc. Res. 40:436-437.
28. Yusuf, S., Al-Saady, N., and Camm, J. 2003. J. Cardiovasc. Electrophysiol. 14:209-214.
29. Zaccolo, M., Malgalhaes, P., and Pozzan, T. 2002. Curr. Opin. Cell. Biol. 14:160-166.
30. Zaccolo, M., and Pozzan, T. 2003. Trends Neurosci. 26:53-55.